A. Peacock (Glasgow, United Kingdom), D. Montani (Kremlin Bicêtre, France)
LATE-BREAKING ABSTRACT: Pulmonary hypertension in Portugal: First data from a nationwide registry
R. Baptista, J. Meireles, A. Agapito, G. Castro, A. Marinho da Silva, T. Shiang, A. Oliveira, D. Ferreira, F. Gonçalves, S. Robalo-Martins, A. Nunes Diogo, A. Reis (Coimbra, Porto, Lisboa, Vila Nova de Gaia, Portugal)
|    |
Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors
F. León, G. Pérez-Peñate, J. Navarro, G. Juliá, A. García, C. Cabrera, P. Cabrera, N. Ojeda, J. Pulido, I. Rúa Figueroa (Las Palmas de Gran Canaria, Spain)
| |
External validation of the French predictive model to estimate PAH survival: A REVEAL analysis
M. McGoon, R. Benza, A. Frost, D. Badesch, C.G. Elliott, O. Sitbon, G. Simonneau, D. Miller, E. Muros Le Rouzic, M. Humbert (Rochester, Pittsburgh, Houston, Aurora, Murray, Salt Lake City, San Francisco, United States Of America; Le Kremlin Bicêtre, France; Allschwil, Switzerland)
| |
External validation of the REVEAL risk score calculator for PAH survival: A French pulmonary hypertension network analysis
O. Sitbon, M. Humbert, G. Simonneau, J.C. Lemarie, D. Miller, E. Muros Le Rouzic, V. Gressin, D. Badesch, R. Benza, C.G. Elliott, A. Frost, M. McGoon (Le Kremlin Bicêtre, Paris, France; San Francisco, Aurora, Pittsburgh, Murray, Houston, Rochester, United States Of America; Allschwil, Switzerland)
| |
Baseline characteristics of idiopathic PAH patients with severely reduced diffusion capacity
P. Trip, E. Nossent, A. Boonstra, H.J. Bogaard, F. de Man, N. Westerhof, K. Grunberg, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
‘Idiopathic‘ pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival
Y. Ling, M. Johnson, D. Kiely, R. Condliffe, C. Elliot, J.S.R. Gibbs, L. Howard, J. Pepke-Zaba, K. Sheares, P. Corris, A. Fisher, J. Lordan, S. Gaine, J.G. Coghlan, S.J. Wort, M. Gatzoulis, A. Peacock (Glasgow, Sheffield, London, Cambridge, Newcastle, United Kingdom; Dublin, Ireland)
| |
Hepatopulmonary syndrome: Long-term survival in the Mayo Clinic experience
V. Iyer, K. Swanson, R. Cartin-ceba, M. Krowka (Rochester, United States Of America)
| |
Survival in patients with different groups of pulmonary hypertension
H. Tiede, J. Felix, E. Steyerberg, M. Wilkins, O. Franco, J. Witteman, W. Seeger, F. Grimminger, A. Ghofrani (Giessen, Germany; Rotterdam, Netherlands; London, United Kingdom)
| |